scispace - formally typeset
L

Lucio G. Costa

Researcher at University of Washington

Publications -  365
Citations -  18710

Lucio G. Costa is an academic researcher from University of Washington. The author has contributed to research in topics: Muscarinic acetylcholine receptor & Carbachol. The author has an hindex of 68, co-authored 359 publications receiving 17160 citations. Previous affiliations of Lucio G. Costa include Sapienza University of Rome & University of Bari.

Papers
More filters
Journal ArticleDOI

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

TL;DR: When fed on a high-fat, high-cholesterol diet, PON1 -null mice were more susceptible to atherosclerosis than their wild-type littermates.
Journal ArticleDOI

Xestospongins: Potent Membrane Permeable Blockers of the Inositol 1,4,5-Trisphosphate Receptor

TL;DR: Xe's represent a new class of potent, membrane permeable IP3 receptor blockers exhibiting a high selectivity over ryanodine receptors and are a valuable tool for investigating the structure and function of IP3 receptors and Ca2+ signaling in neuronal and nonneuronal cells.
Journal ArticleDOI

Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants

TL;DR: Levels of PBDEs causing developmental neurotoxicity in animals are not much dissimilar from levels found in highly exposed infants and toddlers, and these levels have been increasing in the past 30 years.
Journal ArticleDOI

Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment.

TL;DR: The results of this review demonstrate that the use of urinary 3,5,6-trichlorpyridinol (TCPy), a metabolite of chlorpyrifos as a biomarker of nonoccupational exposure is problematic and may overestimate non Occupational exposures to chlorparyifos by 10-to 20-fold because of the widespread presence of both TCPy and chlorp Pyrifos-methyl in the food supply.
Journal ArticleDOI

Polyphenols and health: what compounds are involved?

TL;DR: It is concluded that uncritical judgements made on the basis of the published literature, particularly about toxicity and bioactivity, may sometimes have been misled and misleading and bioavailability values reported in the literature for phenolic compounds should be strongly reconsidered in the light of the large number of newly identified circulating and excreted metabolites.